Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy

NCT07088354 · clinicaltrials.gov ↗
RECRUITING
Status
300
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Tongji Hospital